000 01333 a2200397 4500
005 20250512091828.0
264 0 _c19860304
008 198603s 0 0 eng d
022 _a0140-6736
024 7 _a10.1016/s0140-6736(71)90602-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWalder, B K
245 0 0 _aSkin cancer and immunosuppression.
_h[electronic resource]
260 _bLancet (London, England)
_cDec 1971
300 _a1282-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAzathioprine
_xadverse effects
650 0 4 _aCarcinoma, Basal Cell
_xchemically induced
650 0 4 _aCarcinoma, Squamous Cell
_xchemically induced
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aKeratoacanthoma
_xchemically induced
650 0 4 _aKidney Transplantation
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPrednisone
_xadverse effects
650 0 4 _aRisk
650 0 4 _aSkin Diseases
_xchemically induced
650 0 4 _aSkin Neoplasms
_xchemically induced
700 1 _aRobertson, M R
700 1 _aJeremy, D
773 0 _tLancet (London, England)
_gvol. 2
_gno. 7737
_gp. 1282-3
856 4 0 _uhttps://doi.org/10.1016/s0140-6736(71)90602-7
_zAvailable from publisher's website
999 _c4149050
_d4149050